---
authors:
- Johns, Tracy
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/40378319/
file_path: 2025/05/sodium-glucose-cotransporter-2-inhibitors-for-people-with-ch.md
issue: '5'
keywords:
- Diabetes
last_updated: '2025-07-30'
original_format: PubMed
pages: 404-405
patient_population: Adults
peer_reviewed: true
pmid: '40378319'
processed_date: '2025-07-30'
publication_date: '2025-05-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney Disease
  and Diabetes.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '40378319'
  title: Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney
    Disease and Diabetes.
  authors:
  - last_name: Johns
    fore_name: Tracy
    initials: T
    affiliation: SF College of Medicine, Tampa, Florida.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '5'
  publication_info:
    year: '2025'
    month: '05'
    full_date: '2025-05-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '40378319'
  title: Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney
    Disease and Diabetes.
  authors:
  - name: Johns T
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 May
- pmid: '38365744'
  title: 'Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled
    trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose
    cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes
    (the OTID trial).'
  authors:
  - name: Al-Ozairi E
    authtype: Author
    clusterid: ''
  - name: Narula K
    authtype: Author
    clusterid: ''
  - name: Miras AD
    authtype: Author
    clusterid: ''
  - name: Taghadom E
    authtype: Author
    clusterid: ''
  - name: Samad AE
    authtype: Author
    clusterid: ''
  - name: Al Kandari J
    authtype: Author
    clusterid: ''
  - name: Alyosef A
    authtype: Author
    clusterid: ''
  - name: Mashankar A
    authtype: Author
    clusterid: ''
  - name: Al-Najim W
    authtype: Author
    clusterid: ''
  - name: le Roux CW
    authtype: Author
    clusterid: ''
  source: Trials
  pubdate: 2024 Feb 16
- pmid: '38174341'
  title: Narrative review investigating the nephroprotective mechanisms of sodium
    glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with
    chronic kidney disease.
  authors:
  - name: Speedtsberg ES
    authtype: Author
    clusterid: ''
  - name: Tepel M
    authtype: Author
    clusterid: ''
  source: Front Endocrinol (Lausanne)
  pubdate: '2023'
- pmid: '34846711'
  title: 'Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment
    Landscape.'
  authors:
  - name: Mende CW
    authtype: Author
    clusterid: ''
  source: Adv Ther
  pubdate: 2022 Jan
- pmid: '29963920'
  title: Effects of sodium glucose co-transporter 2 inhibitors on the kidney.
  authors:
  - name: de Albuquerque Rocha N
    authtype: Author
    clusterid: ''
  - name: Neeland IJ
    authtype: Author
    clusterid: ''
  - name: McCullough PA
    authtype: Author
    clusterid: ''
  - name: Toto RD
    authtype: Author
    clusterid: ''
  - name: McGuire DK
    authtype: Author
    clusterid: ''
  source: Diab Vasc Dis Res
  pubdate: 2018 Sep
---

# Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney Disease and Diabetes.

**Authors:** Johns, Tracy

**Published in:** American family physician | Vol. 111, No. 5 | 2025-05-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/40378319/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/40378319/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
